dacarbazine has been researched along with Lymphoma in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 50 (40.32) | 18.7374 |
1990's | 11 (8.87) | 18.2507 |
2000's | 26 (20.97) | 29.6817 |
2010's | 31 (25.00) | 24.3611 |
2020's | 6 (4.84) | 2.80 |
Authors | Studies |
---|---|
Goddard, PM; Wilman, DE | 1 |
Giulino-Roth, L; Rodriguez-Hernandez, A | 1 |
Cutter, DJ; Daly, P; Duane, FK; Gillham, C; Houlihan, OA; McArdle, O; Ntentas, G | 1 |
Bromberg, JEC; Doorduijn, JK | 1 |
Peccatori, FA; Pirosa, MC | 1 |
Wei, Y; Yuan, Z; Zhang, J; Zhong, W | 1 |
Armand, P; Batchelor, TT; Chen, YB; DeFilipp, Z; El-Jawahri, A; Li, S; Nayak, L; Wang, N | 1 |
Baines, SJ; Blackwood, L; Elliott, JW; Treggiari, E | 1 |
Iranshahi, M; Naserian, M; Ramazani, E; Tayarani-Najaran, Z | 1 |
Hasséus, B; Johansson, JE; Jonasson, P; Skallsjö, K | 1 |
Abramson, JS; Batchelor, TT; Clark, SW; Taylor, J; Wang, DL | 1 |
Austin, AD; Desjardins, A; Friedman, HS; Herndon, JE; Jiang, X; McLendon, RE; Quinn, JA; Reardon, DA; Vredenburgh, JJ | 1 |
Finnes, H; Kenderian, SS; Rana, V; Sonbol, MB; Witzig, TE | 1 |
Aaløkken, TM; Bogsrud, TV; Geier, OM; Hagtvedt, T; Holte, H; Lund, KV; Løndalen, AM; Seierstad, T; Smith, HJ | 1 |
Bai, B; Cai, QC; Cai, QQ; Gao, Y; Huang, HQ; Jiang, WQ; Wang, XX; Xia, YF; Xia, ZJ | 1 |
Canal, F; Cavallin, S; Dei Tos, AP; Gherlinzoni, F; Scarpa, M; Scquizzato, E; Stefani, PM; Toffolatti, L | 1 |
Gned, D; Parvis, G; Priola, AM; Priola, SM; Torti, D | 1 |
Aaløkken, TM; Hagtvedt, T; Smith, HJ | 1 |
Geiger, TM; Grayson, BL; Kauffmann, RM; Mosse, CA | 1 |
Bayman, E; Gilson, D; Murray, L; Prestwich, RJ; Robertshaw, H; Sethugavalar, B; Thomas, E | 1 |
Barrié, M; Benouaich-Amiel, A; Chinot, O; Choquet, S; del Rio, MS; Delgadillo, D; Delwail, V; Ghesquieres, H; Gonzalez-Aguilar, A; Gressin, R; Gyan, E; Hoang-Xuan, K; Houillier, C; Huchet, A; Lacomblez, L; Lamy, T; Lebouvier-Sadot, S; Omuro, A; Soubeyran, P; Soussain, C; Taillandier, L; Tanguy, ML; Touitou, V | 1 |
Bierman, PJ; Bociek, RG; Kallam, A | 1 |
Arakelyan, S; Avagyan, A; Bardakchyan, S; Danielyan, S; Hakobyan, L; Harutyunyan, L; Iskanyan, S; Safaryan, L; Sargsyan, L; Tamamyan, G; Voskanyan, A; Zohrabyan, D | 1 |
Augspurger, M; Bartlett, NL; Bokstein, F; Bovi, JA; Brat, D; Fisher, BJ; Glass, J; Liepman, MK; Mehta, MP; Schultz, CJ; Solhjem, MC; Suh, JH; Werner-Wasik, M; Won, M | 1 |
Bodaghi, B; Cassoux, N; Choquet, S; Costopoulos, M; Hoang-Xuan, K; Houillier, C; Le Cossec, C; Legarf-Tavernier, M; LeHoang, P; Nguyen, DT; Omuro, A; Soussain, C; Touitou, V | 1 |
Chen, L; Dinca, EB; James, CD; Kadoch, C; Karrim, J; Lowell, CA; Nguyen, D; Parikh, S; Rubenstein, JL; Shuman, MA; Treseler, PA; Voicu, R | 1 |
Endo, K; Higuchi, T; Kuji, I; Matsuda, H; Murakami, K; Nakajima, K; Oriuchi, N; Tsukamoto, N | 1 |
Glas, M; Herrlinger, U; Kurzwelly, D; Lohner, H; Reifenberger, G; Roth, P; Schabet, M; Waha, A; Weimann, E; Weller, M | 1 |
Yamanaka, R | 1 |
Fang, Q; Wang, JS; Yang, M; Yang, Y; Yuan, J; Zhang, W | 1 |
Song, YQ; Zhu, J | 1 |
Fujino, Y; Goto-Koshino, Y; Nakayama, H; Ohno, K; Takeuchi, Y; Tsujimoto, H; Uchida, K | 1 |
Decanter, C; Dewailly, D; Gallo, C; Lefebvre, C; Morschhauser, F; Pigny, P | 1 |
Cummings, J; Dive, C; Greystoke, A; Hughes, A; Illidge, TM; Linton, K; Maders, F; O'Connor, JP; Radford, J; Ranson, M; Taylor, MB; Ward, T | 1 |
Caviedes, I; Córdova, A; Delgado, IO; Goset, KC; Sánchez-Nieto, B | 1 |
Hide, T; Kuratsu, J; Makino, K; Nakamura, H | 1 |
Asano, S; Fujimaki, T; Hoya, K; Ishida, Y; Matsuno, A; Murakami, M; Nakaguchi, H; Yamada, SM; Yamazaki, K | 1 |
Hotta, T; Shimoyama, M; Tobinai, K; Tsukasaki, K | 1 |
Behler, CM; Cha, S; Damon, LE; Hwang, J; Issa, S; McDermott, M; O'Brien, J; Rubenstein, JL; Shuman, MA; Treseler, P; Valles, F; Wieduwilt, MJ | 1 |
Evens, A; Osborne, CK | 1 |
Falchi, L; Ferranti, L; Gunnellini, M; Liberati, AM | 1 |
Abrey, LE; Deangelis, LM; Drappatz, J; Gilbert, MR; Nayak, L; Omuro, A; Prados, M; Reardon, DA; Wen, PY | 1 |
Cher, L; Gan, HK; Wong, SF | 1 |
Bökönyi, G; Horváth, A; Kéri, G; Szende, B | 1 |
D'Amati, G; Graziani, G; Kalish, V; Leonetti, C; Portarena, I; Scarsella, M; Tentori, L; Vergati, M; Xu, W; Zhang, J; Zupi, G | 1 |
Angelopoulou, MK; Doussis-Anagnostopoulou, I; Kittas, C; Pangalis, GA; Siakantaris, MP; Vassilakopoulos, TP | 1 |
Barron, L; Tishler, R; Wong, ET; Wu, JK | 1 |
Abbadessa, A; Bernardi, D; Bordonaro, R; Candela, M; Dell'Oro, S; Ferreri, AJ; Franceschi, E; Latte, G; Mason, W; Pace, A; Perry, J; Reni, M; Stelitano, C; Villa, E; Zaja, F | 1 |
Erdoğan, S; Ergin, M; Hakverdi, S; Hazar, B; Seyrek, E; Tuncer, I | 1 |
Grigg, A | 1 |
Arrigo, C; Pitini, V; Righi, M | 1 |
Wong, ET | 1 |
Benouaich-Amiel, A; Delattre, JY | 1 |
Altavilla, G; Arrigo, C; Baldari, S; Naro, C; Perniciaro, F; Pitini, V | 1 |
Delattre, JY; Sanson, M | 1 |
Abbadessa, A; Bordonaro, R; Candela, M; Corazzelli, G; Faedi, M; Ferreri, AJ; Franceschi, E; Ilariucci, F; Latte, G; Manno, P; Mason, W; Mazza, E; Pace, A; Perry, J; Reni, M; Spina, M; Stelitano, C; Zaja, F | 1 |
Ataullakhanov, FI; Galkina, NM; Kulikova, EV; Medvedev, PV; Pivnik, AV; Skorokhod, O; Vitvitsky, VM; Zybunova, EE | 1 |
Aristu, J; De la Cruz, S; Fernández Hidalgo, O; Nieto, Y; Santisteban, M; Zubieta, JL | 1 |
Cadile, CD; Dervisis, NG; Dominguez, PA; Kitchell, BE; Newman, RG; Sarbu, L; Swanson, CN | 1 |
Barrie, M; Carnin, C; Chinot, O; Hoang-Xuan, K; Omuro, AM; Taillandier, L | 1 |
Allen, J; Avery-Kiejda, KA; Hersey, P; Mhaidat, NM; Scott, RJ; Zhang, XD | 1 |
Weller, M | 1 |
Amiel, JL; Ben Ayed, F; Droz, JP; Spielmann, M; Tursz, T | 1 |
Klastersky, J | 1 |
Bonmassar, E; Fioretti, MC; Puccetti, P; Romani, L; Taramelli, D | 1 |
Canti, G; Festenstein, H; Marelli, O; Nicolin, A; Testorelli, C | 1 |
Bonmassar, E; Campanile, F; Iorio, AM | 1 |
Fuggetta, MP; Giuliani, A; Goldin, A; Guadagni, F; Perno, CF; Roselli, M | 1 |
Bonmassar, E; Fioretti, MC; Nardelli, B; Puccetti, P; Romani, L; Sava, G | 1 |
Kosumi, N; Mizoguchi, M; Shimizu, T; Takeshima, M; Yanagawa, S | 1 |
Bonmassar, E; Fioretti, MC; Migliorati, G; Romani, L | 1 |
Gleiser, CA; Gray, KN; Jardine, JH; Raulston, GL | 1 |
Ichihashi, M; Inoi, T; Mishima, Y; Mojamdar, M | 1 |
Bonmassar, A; Fioretti, MC; Romani, L; Taramelli, D | 1 |
Bonmassar, E; Fioretti, MC; Giampietri, A; Goldin, A | 1 |
Bonmassar, A; Bonmassar, E; Goldin, A; Riccardi, C; Rivosecchi-Merletti, P | 1 |
Bonmassar, E; Enrico, P; Goldin, A; Iorio, AM; Neri, M | 1 |
Bianchi, R; Bonmassar, E; Fioretti, MC; Nardelli, B; Romani, L | 1 |
Franco, P; Mantovani, A; Marelli, O; Nicolin, A | 1 |
Barzi, A; Bonmassar, A; Bonmassar, E; Goldin, A; Rivosecchi-Merletti, P | 1 |
Bartocci, A; Bonmassar, E; Goldin, A; Puccetti, P; Riccardi, C; Spreafico, F | 1 |
Bonmassar, A; Bonmassar, E; Circolo, A; Giampietri, A; Goldin, A; Puccetti, P | 1 |
Tobinai, K | 1 |
Adkins, DR; Boldt, D; Freytes, CO; Irvin, R; Kuhn, J; LeMaistre, CF; Lyons, R; Roodman, GD; Salzman, D; Smith, L | 1 |
Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
Aviles, A; Delgado, S | 1 |
Alpaslan, C; Alpaslan, G; Cetiner, S; Gögen, H; Karadeniz, C; Oğuz, A | 1 |
Bauduer, F; Coiffier, B; Desablens, B | 1 |
Sakumi, K; Sekiguchi, M; Shiraishi, A | 1 |
Dichgans, J; Herrlinger, U; Küker, W; Platten, M; Weller, M | 1 |
Donner, L; Klener, P | 1 |
Franco, P; Goldin, A; Nicolin, A; Testorelli, C | 1 |
Biancifiori, F; Fioretti, MC; Giampietri, A; Puccetti, P; Riccardi, C | 1 |
Goldin, A; Kinney, Y; Santoni, A | 1 |
Luini, W; Mantovani, A; Peri, G; Polentarutti, N; Spreafico, F | 1 |
Andrielli, M; Bianchi, R; Circolo, A; Nardelli, B; Romani, L | 1 |
Bonmassar, E; Fioretti, MC; Romani, L | 1 |
Circolo, A; Giampietri, A; Menconi, E; Puccetti, P | 1 |
Bonmassar, E; Fioretti, MC; Giampietri, A; Goldin, A; Puccetti, P; Riccardi, C | 1 |
Gelfi, P; Marelli, O; Nicolin, A; Nicolotti, G | 1 |
Fioretti, MC; Romani, L | 1 |
Costanzi, JJ | 1 |
Barzi, A; Fioretti, MC; Mantovani, A; Spreafico, F; Vecchi, A | 1 |
Goldin, A; Nicolin, A; Silvestrini, R; Testorelli, C | 1 |
Weisburger, EK | 1 |
Gutterman, JU; Hersh, EM; Mavligit, GM | 1 |
Bonmassar, E; Cudkowicz, G; Franco, P; Goldin, A; Testorelli, C | 1 |
Bonmassar, E; Campanile, F; Gaston, M; Goldin, A; Houchens, DP | 1 |
Maclennan, KA; Okon, E; Polliack, A; Shiloni, E | 1 |
Chang, SC; Hsu, JR; Perng, RP | 1 |
Bulgarini, B; De Vecchis, L; Giuliani, A; Turriziani, M | 1 |
Gescher, A; Quarterman, CP; Slack, JA; Tsang, LL | 1 |
Farmer, PB; Gescher, A; Slack, JA; Tsang, LL | 1 |
Jestrimski, KW; Lowenthal, RM | 1 |
Bonadonna, G | 1 |
DeVita, VT | 1 |
Coiffier, B | 1 |
Borri-Voltattorni, C; Dominici, P; Fioretti, MC; Fuschiotti, P; Puccetti, P; Romani, L | 1 |
Straus, DJ | 1 |
Hatae, Y; Hattori, T; Ishikawa, Y; Nakadate, H; Nishi, M; Takeda, T | 1 |
Fioretti, MC; Grohmann, U; Mage, MG; Principato, GB; Puccetti, P; Romani, L | 1 |
Tisdale, MJ | 1 |
Akahoshi, M; Fuchinoue, M; Hoshino, S; Mizoguchi, H; Oshimi, K; Takada, K; Takahashi, M; Yamada, O | 1 |
Archetti, YL; Aresca, P; Del Vecchio, L; Testorelli, C | 1 |
10 review(s) available for dacarbazine and Lymphoma
Article | Year |
---|---|
Lymphomas in pregnancy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Pregnancy; Vinblastine | 2023 |
Stem Cell as Vehicles of Antibody in Treatment of Lymphoma: a Novel and Potential Targeted Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Stem Cells; Vinblastine | 2021 |
[Medical management of primary central nervous system lymphoma refractory or resistant to standard of care treatment].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Dacarbazine; Drug Discovery; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Methotrexate; Neoplasm Recurrence, Local; Rituximab; Salvage Therapy; Temozolomide; Topotecan | 2009 |
Lymphoma study group of JCOG.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Approval; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Japan; Kaplan-Meier Estimate; Lymphoma; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Staging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Randomized Controlled Trials as Topic; Vincristine | 2012 |
The impact of conventional and high-dose therapy for lymphoma on fertility.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility; Hodgkin Disease; Hormone Replacement Therapy; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Prednisolone; Treatment Outcome; Vinblastine; Vincristine | 2004 |
[Update on cerebral tumors].
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Glioma; Humans; Lymphoma; Radiosurgery; Temozolomide | 2006 |
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Salvage Therapy; Vinblastine; Vincristine | 1995 |
Corticosteroid drugs: their role in oncological practice.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Dyspnea; Fluorouracil; Hodgkin Disease; Humans; Hypercalcemia; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Melphalan; Methotrexate; Multiple Myeloma; Palliative Care; Prednisone; Procarbazine; Receptors, Glucocorticoid; Vinblastine; Vincristine; Vomiting | 1986 |
Chemotherapy of malignant lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine | 1985 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
18 trial(s) available for dacarbazine and Lymphoma
Article | Year |
---|---|
O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Female; Humans; Longitudinal Studies; Lymphoma; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Retrospective Studies; Temozolomide | 2013 |
Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Early Diagnosis; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lymphoma; Male; Middle Aged; Multimodal Imaging; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Young Adult | 2015 |
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Prospective Studies; Quality of Life; Temozolomide; Treatment Outcome; Vincristine | 2015 |
Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemoradiotherapy; Dacarbazine; Disease-Free Survival; Female; Humans; Induction Chemotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Rituximab; Temozolomide; Whole-Body Irradiation; Young Adult | 2016 |
Primary Oculocerebral Lymphoma: MTX Polychemotherapy Alone on Intraocular Disease Control.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellum; Cytarabine; Dacarbazine; Eye Neoplasms; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Survival Analysis; Temozolomide; Vincristine | 2016 |
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Consolidation Chemotherapy; Cytarabine; Dacarbazine; Diffusion Magnetic Resonance Imaging; Etoposide; Female; Humans; Immunotherapy; Lymphoma; Male; Methotrexate; Middle Aged; Prognosis; Remission Induction; Rituximab; Survival Analysis; Temozolomide; Treatment Outcome | 2012 |
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain; Central Nervous System Neoplasms; Dacarbazine; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Rituximab; Salvage Therapy; Temozolomide; Treatment Outcome | 2013 |
Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Central Nervous System Diseases; Dacarbazine; Female; Humans; Lymphoma; Male; Middle Aged; Prospective Studies; Salvage Therapy; Survival Analysis; Temozolomide; Treatment Outcome | 2004 |
Temozolomide as salvage treatment in primary brain lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Temozolomide | 2007 |
Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma.
Topics: Animals; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dog Diseases; Dogs; Drug Resistance, Neoplasm; Female; Lymphoma; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Analysis; Temozolomide; Time Factors; Treatment Outcome | 2007 |
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly.
Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Retrospective Studies; Temozolomide; Treatment Outcome | 2007 |
[Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
Topics: Adolescent; Adult; Bleomycin; Cisplatin; Clinical Trials as Topic; Dacarbazine; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Vinblastine; Vindesine | 1982 |
Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Hypocalcemia; Hypotension; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Remission Induction; Transplantation, Autologous | 1994 |
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Female; Granisetron; Humans; Lymphoma; Male; Middle Aged; Prednisone; Vomiting | 1999 |
DTIC (NSC-45388) studies in the southwest oncology group.
Topics: Carmustine; Chlorpromazine; Clinical Trials as Topic; Dacarbazine; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Lymphoma; Melanoma; Nausea; Neoplasm Metastasis; Remission, Spontaneous; Thrombocytopenia; Triazenes; Vincristine; Vomiting | 1976 |
Characterisation of urinary metabolites of temozolomide in humans and mice and evaluation of their cytotoxicity.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Dacarbazine; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Lymphoma; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Microsomes, Liver; Oxidation-Reduction; Temozolomide; Thymus Neoplasms; Triazines; Tumor Cells, Cultured | 1990 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
97 other study(ies) available for dacarbazine and Lymphoma
Article | Year |
---|---|
Tumor inhibitory triazenes. 2. Variation of antitumor activity within an homologous series.
Topics: Animals; Antineoplastic Agents; Female; Lymphoma; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Solubility; Structure-Activity Relationship; Triazenes | 1980 |
The ABVD's of cooperative trials in pediatric Hodgkin lymphoma: The India experience.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Vinblastine | 2022 |
Predicted cardiac and second cancer risks for patients undergoing VMAT for mediastinal Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breath Holding; Cardiovascular Diseases; Dacarbazine; Doxorubicin; Female; Heart; Hodgkin Disease; Humans; Lymphoma; Mediastinal Neoplasms; Neoplasms, Second Primary; Organs at Risk; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Vinblastine | 2023 |
Is there a future for maintenance temozolomide chemotherapy in PCNSL?
Topics: Brain; Dacarbazine; Humans; Lymphoma; Methotrexate; Temozolomide | 2023 |
High-dose chemotherapy with thiotepa, busulfan, and cyclophosphamide and autologous stem cell transplantation for patients with primary central nervous system lymphoma in first complete remission.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Busulfan; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dacarbazine; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Methotrexate; Middle Aged; Mucositis; Remission Induction; Retrospective Studies; Rituximab; Stem Cell Transplantation; Temozolomide; Thiotepa; Transplantation Conditioning; Transplantation, Autologous | 2017 |
Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Databases, Factual; Dog Diseases; Dogs; Doxorubicin; Kaplan-Meier Estimate; Lymphoma; Recurrence; Retrospective Studies; Survival; Temozolomide; Treatment Outcome; United Kingdom | 2018 |
The Role of SAPK/JNK Pathway in the Synergistic Effects of Metformin and Dacarbazine on Apoptosis in Raji and Ramos Lymphoma Cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Humans; Hypoglycemic Agents; Lymphoma; MAP Kinase Signaling System; Metformin | 2018 |
Apical periodontitis as potential source of infection in patients with lymphoma treated with chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infections; Lymphoma; Male; Periapical Periodontitis; Prospective Studies; Retrospective Studies; Root Canal Therapy; Vinblastine | 2020 |
Plasmablastic lymphoma after standard-dose temozolomide for newly diagnosed glioblastoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Glioblastoma; Humans; Lymphoma; Male; Temozolomide | 2013 |
Therapeutic options for patients with lymphoma and liver dysfunction or failure during mechlorethamine shortage.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Liver Diseases; Lymphoma; Male; Mechlorethamine; Middle Aged; Positron-Emission Tomography; Prednisone; Rituximab; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Neutropenia; Remission Induction; Temozolomide; Thrombocytopenia; Treatment Outcome; Young Adult | 2014 |
MGMT promoter methylation and correlation with protein expression in primary central nervous system lymphoma.
Topics: Adult; Aged; Biomarkers, Tumor; Central Nervous System Neoplasms; Dacarbazine; DNA Methylation; Female; Humans; Immunohistochemistry; Lymphoma; Male; Middle Aged; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Temozolomide | 2014 |
Usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Tomography, X-Ray Computed; Vinblastine | 2015 |
Response to "usefulness of diffusion-weighted magnetic resonance imaging for assessing early treatment response in lymphoma patients".
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Diffusion Magnetic Resonance Imaging; Doxorubicin; Female; Head and Neck Neoplasms; Humans; Lymphoma; Male; Tomography, X-Ray Computed; Vinblastine | 2015 |
Perineal lymphoma: a diagnostic dilemma.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Biopsy; Bleomycin; Cyclophosphamide; Dacarbazine; Debridement; Diagnosis, Differential; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Perineum; Positron-Emission Tomography; Prednisone; Vinblastine; Vincristine | 2014 |
Involved Node, Site, Field and Residual Volume Radiotherapy for Lymphoma: A Comparison of Organ at Risk Dosimetry and Second Malignancy Risks.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Humans; Lymphatic Irradiation; Lymphoma; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Neoplasms, Second Primary; Organs at Risk; Radiotherapy; Radiotherapy Dosage; Risk Assessment; Vinblastine; Young Adult | 2015 |
Kikuchi's Disease Masquerading As Refractory Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Histiocytic Necrotizing Lymphadenitis; Hodgkin Disease; Humans; Lymphoma; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Vinblastine | 2016 |
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Developed Countries; Doxorubicin; Etoposide; Female; Hodgkin Disease; Hospitals; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult | 2016 |
Pathologic correlates of primary central nervous system lymphoma defined in an orthotopic xenograft model.
Topics: Animals; Brain Neoplasms; Cell Polarity; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Humans; Interleukin-4; Luminescent Measurements; Lymphoma; Macrophages; Mice; Mice, Nude; STAT6 Transcription Factor; Temozolomide; Tumor Suppressor Proteins | 2009 |
[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Prognosis; Radiopharmaceuticals; Rituximab; Vinblastine; Vincristine; Young Adult | 2009 |
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Geriatrics; Humans; Lymphoma; Male; Middle Aged; Promoter Regions, Genetic; Retrospective Studies; Survival Analysis; Temozolomide; Tumor Suppressor Proteins | 2010 |
[Study on mesenchymal stem cells mediated enzyme-prodrug gene CYP1A2 targeting anti-tumor effect].
Topics: Apoptosis; Bone Marrow Cells; Cells, Cultured; Cytochrome P-450 CYP1A2; Dacarbazine; Genetic Vectors; Humans; Lymphoma; Male; Mesenchymal Stem Cells; Transfection | 2009 |
[Management of lymphoma with respect to pathologic classification: updates and controversies].
Topics: Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Prednisone; Receptor Protein-Tyrosine Kinases; Rituximab; Vinblastine; Vincristine | 2009 |
Long term survival of primary skeletal muscle lymphoma in a miniature dachshund.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dacarbazine; Dogs; Female; Femoral Neoplasms; Lymphoma; Melphalan; Muscle Neoplasms; Ovariectomy; Prednisolone; Survivors; Tomography, X-Ray Computed | 2010 |
Anti-Müllerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results.
Topics: Adult; Anti-Mullerian Hormone; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lymphoma; Ovary; Time Factors; Vinblastine | 2010 |
Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Pharmacological; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Dacarbazine; DNA; Doxorubicin; Female; fms-Like Tyrosine Kinase 3; Humans; Keratin-18; Lymphoma; Male; Middle Aged; Nucleosomes; Predictive Value of Tests; Prednisone; Prognosis; Rituximab; Vinblastine; Vincristine; Young Adult | 2011 |
Predictive models for pulmonary function changes after radiotherapy for breast cancer and lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Lung; Lymphoma; Male; Middle Aged; Models, Biological; Multivariate Analysis; Organs at Risk; Prednisone; Prospective Studies; Pulmonary Diffusing Capacity; Radiation Injuries; Radiotherapy Dosage; Respiratory Function Tests; Smoking; Spirometry; Vinblastine; Vincristine; Young Adult | 2012 |
Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Middle Aged; Salvage Therapy; Survival Analysis; Temozolomide; Tumor Suppressor Proteins | 2012 |
Combination therapy with rituximab and temozolomide for recurrent and refractory primary central nervous system lymphoma.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Central Nervous System Neoplasms; Dacarbazine; Drug Therapy, Combination; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Temozolomide | 2011 |
Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting.
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Fertility Preservation; Humans; Lapatinib; Lymphoma; Molecular Targeted Therapy; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Quinazolines; Receptor, ErbB-2; Rituximab; Trastuzumab; Vinblastine; Vincristine | 2011 |
High-dose methotrexate and temozolomide associated with intrathecal liposomal cytarabine for the treatment of primary or secondary central nervous system lymphoma: a preliminary experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Dacarbazine; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Nervous System; Temozolomide | 2012 |
A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy; Survival Analysis; Temozolomide | 2012 |
Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Disease Models, Animal; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Male; Melanoma, Experimental; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Peptides, Cyclic; Somatostatin; Xenograft Model Antitumor Assays | 2003 |
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Drug Synergism; Enzyme Inhibitors; Glioblastoma; Humans; Lymphoma; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Survival Rate; Temozolomide; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Correspondence re: M. Provencio, et al. the topoisomerase IIa expression correlates with survival in patients with advanced Hodgkin's lymphoma. Clin. Cancer Res., 9: 1406-1411, 2003.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; DNA Topoisomerases, Type II; DNA-Binding Proteins; Doxorubicin; Female; Humans; Lymphoma; Male; Middle Aged; Survival Rate; Vinblastine | 2003 |
Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dacarbazine; Drug Synergism; Humans; Lymphoma; Middle Aged; Neoplasm Recurrence, Local; Rituximab; Temozolomide; Treatment Outcome | 2004 |
Cyclooxygenase-2 (Cox-2) expression in lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclooxygenase 2; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Isoenzymes; Life Tables; Lymphoma; Lymphoma, Non-Hodgkin; Male; Membrane Proteins; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Prednisone; Prostaglandin-Endoperoxide Synthases; Survival Analysis; Vinblastine; Vincristine | 2004 |
Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Central Nervous System Neoplasms; Dacarbazine; Humans; Lymphoma; Rituximab; Temozolomide | 2004 |
Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Clinical Trials, Phase I as Topic; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Hematologic Diseases; Humans; Kidney; Lymphoma; Maximum Tolerated Dose; Meningeal Neoplasms; Neoplasm Recurrence, Local; Rituximab; Temozolomide; Treatment Outcome | 2005 |
Salvage therapy for primary central nervous system lymphoma with (90)Y-Ibritumomab and Temozolomide.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Female; Humans; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Radioimmunotherapy; Remission Induction; Salvage Therapy; Survival Rate; Temozolomide; Yttrium Radioisotopes | 2007 |
[Cerebral tumours in the adult. A real increase].
Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dacarbazine; Glioma; Humans; Incidence; Lymphoma; Magnetic Resonance Imaging; Microarray Analysis; Neuronavigation; Patient Care Team; Prognosis; Prospective Studies; Quality of Life; Radiosurgery; Radiotherapy, Conformal; Temozolomide | 2006 |
Doxorubicin pharmacokinetics in lymphoma patients treated with doxorubicin-loaded eythrocytes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion, Autologous; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Carriers; Erythrocyte Transfusion; Erythrocytes; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Vinblastine; Vincristine | 2007 |
Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brain; Central Nervous System Neoplasms; Dacarbazine; Female; Humans; Lymphatic Irradiation; Lymphoma; Magnetic Resonance Imaging; Middle Aged; Radiography; Rituximab; Temozolomide | 2007 |
Temozolomide induces senescence but not apoptosis in human melanoma cells.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Benzothiazoles; Cell Division; Cellular Senescence; Dacarbazine; G2 Phase; Humans; Lymphoma; Melanoma; O(6)-Methylguanine-DNA Methyltransferase; Temozolomide; Toluene; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2007 |
[Chemotherapy for brain tumors in adult patients].
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Combined Modality Therapy; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Genetic Markers; Glioma; Humans; Lymphoma; Prognosis; Promoter Regions, Genetic; Temozolomide; Topotecan; Tumor Suppressor Proteins | 2008 |
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine | 1982 |
Drug-mediated changes of tumour cell immunogenicity and antigenicity.
Topics: Animals; Antigens, Neoplasm; Cell Line; Dacarbazine; Epitopes; Female; Histocompatibility Antigens; Immunotherapy; Leukemia, Experimental; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental | 1982 |
Immunological cross-reactivity between H-2Dk product and DTIC-treated H-2d lymphoma.
Topics: Animals; Cross Reactions; Dacarbazine; Epitopes; H-2 Antigens; Immunity, Cellular; In Vitro Techniques; Leukemia L1210; Lymphoma; Mice; Mice, Inbred Strains | 1982 |
Natural resistance of mice pretreated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) + cyclophosphamide (Cy) against virus-induced lymphoma cells.
Topics: Animals; Cell Transformation, Viral; Cyclophosphamide; Dacarbazine; Idoxuridine; Immunity, Innate; Killer Cells, Natural; Liver; Lung; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred CBA; Species Specificity; Spleen | 1984 |
Increased immunogenicity of murine lymphoma cells following exposure to gamma rays in vivo.
Topics: Animals; Carmustine; Dacarbazine; Gamma Rays; Histocompatibility Antigens; Immune Tolerance; Immunity; Leukemia L1210; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1984 |
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.
Topics: Animals; Antibody Formation; Antigens, Neoplasm; Dacarbazine; Graft Rejection; Graft vs Host Disease; Graft vs Host Reaction; Hypersensitivity, Delayed; Immune Tolerance; Immunosuppressive Agents; Immunotherapy; Lymphocyte Activation; Lymphoma; Mice; Spleen; Structure-Activity Relationship; Triazenes | 1984 |
[T cell lymphoma successfully treated with multiple chemotherapy including DTIC].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Lymphoma; Middle Aged; Prednisolone; T-Lymphocytes; Vincristine | 1983 |
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro.
Topics: Animals; Antigens, Neoplasm; Cytotoxicity, Immunologic; Dacarbazine; Immunity, Innate; Killer Cells, Natural; Lymphoma; Mice | 1983 |
Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dog Diseases; Dogs; Doxorubicin; Female; Lymphoma; Male; Prognosis | 1984 |
[Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
Topics: Cysteinyldopa; Dacarbazine; Dihydroxyphenylalanine; Female; Humans; Lymphoma; Melanoma; Middle Aged; Skin Neoplasms | 1982 |
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo.
Topics: Animals; Antigens, Neoplasm; Dacarbazine; Female; Histocompatibility Antigens; Lymphoma; Male; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Transplantation Immunology; Tumor Cells, Cultured | 1980 |
Drug-mediated antigenic changes in murine leukemia cells: antagonistic effects of quinacrine, an antimutagenic compound.
Topics: Animals; Antigens, Neoplasm; Dacarbazine; Immunity; Leukemia, Experimental; Lymphoma; Male; Mice; Mice, Inbred Strains; Mutation; Quinacrine | 1980 |
Transplantation resistance of drug-treated hybrid or allogeneic mice against murine lymphomas. I. Immunopharmacology studies.
Topics: Animals; Bone Marrow Cells; Carrageenan; Cyclophosphamide; Dacarbazine; Female; Killer Cells, Natural; Liver; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Spleen; T-Lymphocytes; Transplantation Immunology | 1980 |
Combined effects of natural resistance and chemotherapy against a murine lymphoma in lethally-irradiated mice.
Topics: Animals; Cyclophosphamide; Dacarbazine; Hybridization, Genetic; Immunity, Innate; Liver; Lung; Lymphoma; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Spleen; Whole-Body Irradiation | 1981 |
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo.
Topics: Animals; Blood Transfusion; Brain Neoplasms; Dacarbazine; Immunization; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; T-Lymphocytes; Whole-Body Irradiation | 1982 |
Macrophage antitumor activity induced by the antigenic lymphoma L5178Y/DTIC subline.
Topics: Animals; Cell Line; Cytotoxicity, Immunologic; Dacarbazine; Female; Lymphocytes; Lymphoma; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental | 1982 |
Transplantation resistance of drug-treated allogeneic mice against murine lymphomas--II. Studies with various tumor-host combinations.
Topics: Animals; Cyclophosphamide; Dacarbazine; Female; Graft Rejection; H-2 Antigens; Lymphoma; Male; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation Immunology; Transplantation, Homologous | 1981 |
Combined effects of antineoplastic agents and anti-lymphoma allograft reactions.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Dacarbazine; Female; Histocompatibility; Host vs Graft Reaction; Leukemia L1210; Leukemia, Experimental; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Transplantation, Homologous; Vincristine | 1980 |
Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
Topics: Animals; Cyclophosphamide; Dacarbazine; Female; Graft Rejection; Immunization, Passive; Immunotherapy; Leukemia, Experimental; Lymphocyte Transfusion; Lymphoma; Male; Mice; Transplantation, Homologous | 1981 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |
Disturbances in oral and dental structures in patients with pediatric lymphoma after chemotherapy: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Daunorubicin; Dental Plaque Index; DMF Index; Doxorubicin; Female; Humans; Lymphoma; Male; Maxillofacial Development; Methotrexate; Periodontal Index; Prednisone; Procarbazine; Remission Induction; Survivors; Tooth Abnormalities; Tooth Eruption; Vinblastine; Vincristine | 1999 |
Increased susceptibility to chemotherapeutic alkylating agents of mice deficient in DNA repair methyltransferase.
Topics: Adenoma; Animals; Antineoplastic Agents, Alkylating; Cell Death; Cyclophosphamide; Dacarbazine; Female; Lethal Dose 50; Lung Neoplasms; Lymphoma; Male; Mice; Mice, Knockout; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Testis; Thymus Neoplasms | 2000 |
First-line therapy with temozolomide induces regression of primary CNS lymphoma.
Topics: Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Dacarbazine; Female; Humans; Lymphoma; Male; Middle Aged; Temozolomide | 2002 |
Imidazole carboxamide (DTIC) in the treatment of advanced lymphomas. Efficacy of DTIC in cases which fail to respond to conventional chemotherupetic combinations.
Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Triazenes; Vinblastine; Vincristine | 1977 |
In vitro lymphocyte stimulation and the generation of cytotoxic lymphocytes with drug-induced antigenic lymphomas.
Topics: Animals; Antigens, Neoplasm; Cytotoxicity, Immunologic; Dacarbazine; Epitopes; H-2 Antigens; In Vitro Techniques; Leukemia L1210; Lymphocyte Activation; Lymphocytes; Lymphoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Triazenes | 1978 |
Murine leukemia growth inhibition or enhancement following immunization with tumor cells antigenically altered by drug treatment.
Topics: Animals; Antigens, Neoplasm; Cells, Cultured; Dacarbazine; Female; Floxuridine; Gamma Rays; Idoxuridine; Iodine Radioisotopes; Leukemia, Experimental; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation | 1977 |
Secondary cytotoxic response in vitro against Moloney lymphoma cells antigenically altered by drug treatment in vivo.
Topics: Animals; Antigens, Neoplasm; Cytotoxicity, Immunologic; Dacarbazine; Immunologic Memory; In Vitro Techniques; Leukemia, Experimental; Lymphocyte Culture Test, Mixed; Lymphocytes; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Moloney murine leukemia virus; Tumor Virus Infections | 1978 |
Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
Topics: Animals; Dacarbazine; Daunorubicin; Doxorubicin; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Leukemia L1210; Leukemia, Experimental; Lymphoma; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasms, Experimental | 1979 |
[Transfer in vivo of cytotoxic immune lymphocytes obtained in vitro in primary culture against a murine lymphoma antigenically altered by DTIC].
Topics: Animals; Dacarbazine; Histocompatibility Antigens Class II; Lymphoma; Mice; Neoplasms, Experimental; T-Lymphocytes | 1979 |
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo.
Topics: Animals; Antigens; Cytotoxicity, Immunologic; Dacarbazine; Kinetics; Leukemia L5178; Leukemia, Experimental; Lymphocytes; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Spleen | 1979 |
[Depression of the immune response to lymphoma allotransplant with the use of 5-(3,3-dimethyl-1-triazeno)-imidazol-4-carboxamide (DTIC)].
Topics: Animals; Dacarbazine; Immunosuppression Therapy; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Transplantation Immunology; Transplantation, Homologous; Triazenes | 1977 |
Growth inhibition of normal or drug-treated lymphoma cells in lethally irradiated mice.
Topics: Animals; Antigens, Neoplasm; Cytarabine; Dacarbazine; Female; Graft Rejection; H-2 Antigens; Immunity; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Homologous; Triazenes | 1978 |
Con A agglutination of DTIC-altered lymphoma cells.
Topics: Adsorption; Agglutination; Animals; Cells, Cultured; Concanavalin A; Dacarbazine; Female; Leukemia L1210; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Triazenes | 1978 |
"In vitro" induction of primary cell-mediated immune response to drug-altered lymphoma cells.
Topics: Animals; Cells, Cultured; Cyclophosphamide; Cytotoxicity, Immunologic; Dacarbazine; Leukemia, Experimental; Lymphocytes; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Inbred DBA | 1978 |
The immunodepressive and hematotoxic activity of imidazole-4-carboxamide,5-(3,3-dimethyl-1-triazeno) in mice.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cyclophosphamide; Cytotoxicity Tests, Immunologic; Dacarbazine; Dose-Response Relationship, Immunologic; Hemolytic Plaque Technique; Immunosuppressive Agents; Lymphoma; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Time Factors; Transplantation, Homologous; Triazenes | 1976 |
Cell kinetics and immunoegenicity of lymphoma cells treated with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DIC) in vivo.
Topics: Animals; Cell Line; Dacarbazine; DNA, Neoplasm; Female; Graft Rejection; Leukemia, Experimental; Lymphocytes; Lymphoma; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Homologous; Transplantation, Isogeneic; Triazenes | 1977 |
Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Carcinogens; Dacarbazine; Drug Evaluation, Preclinical; Drug Interactions; Female; Lung Neoplasms; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Neoplasms, Experimental; Peritoneal Neoplasms; Rats; Sarcoma, Experimental | 1977 |
Chemoimmunotherapy of human solid tumors.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Drug Therapy, Combination; Humans; Immunization Schedule; Immunotherapy; Lung Neoplasms; Lymphatic Metastasis; Lymphoma; Melanoma; Neoplasms; Neoplasms, Experimental; Osteosarcoma | 1976 |
Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs.
Topics: Animals; Antigens, Neoplasm; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Fluorouracil; Histocompatibility Antigens; Immunity; Lymphoma; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Nitrosourea Compounds; Pyrazoles; Thioguanine; Transplantation Immunology; Transplantation, Homologous; X-Rays | 1975 |
Increased immunogenicity of two lymphoma lines after drug treatment of athymic (nude) mice.
Topics: Animals; Antibodies, Neoplasm; Cell Line; Dacarbazine; Immunotherapy; Leukemia L1210; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Stimulation, Chemical; Triazenes | 1975 |
Splenic lymphoma in a patient treated with interleukin-2 and dacarbazine for metastatic melanoma.
Topics: Adult; Dacarbazine; Humans; Interleukin-2; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Skin Neoplasms; Splenic Neoplasms | 1992 |
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine | 1990 |
Role of levamisole as immunomodulant in mouse lymphoma model.
Topics: Animals; Carmustine; Cytarabine; Dacarbazine; Drug Synergism; Female; Immune Tolerance; Levamisole; Lymphoma; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Transplantation, Homologous | 1991 |
Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.
Topics: Animals; Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Dacarbazine; Lymphoma; Mice; Prodrugs; Temozolomide; Tumor Cells, Cultured | 1991 |
Hematologic malignancies: non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vinblastine; Vincristine | 1986 |
[Contribution of anthracyclines in treatment of lymphoproliferative disorders].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Multiple Myeloma; Prednisone; Vinblastine; Vincristine | 1987 |
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives.
Topics: Animals; Azacitidine; Carmustine; Cell Line; Cytarabine; Dacarbazine; DNA, Neoplasm; Lymphoma; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Quinacrine; Triazenes | 1987 |
[Treatment of malignant lymphoma in childhood].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Infant; Lymphoma; Male; Prednisone; Vinblastine; Vincristine | 1985 |
Generation of monoclonal antibodies to a chemically xenogenized murine lymphoma.
Topics: Animals; Antibodies, Monoclonal; Cell Survival; Dacarbazine; Immunoglobulin G; Immunoglobulin M; Lymphoma; Mice; Tumor Cells, Cultured | 1988 |
Antitumor imidazotetrazines--XV. Role of guanine O6 alkylation in the mechanism of cytotoxicity of imidazotetrazinones.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line; Chlorambucil; Colonic Neoplasms; Dacarbazine; DNA Repair; Dose-Response Relationship, Drug; Guanine; Humans; Imidazoles; Kinetics; Leukemia, Myeloid, Acute; Lung Neoplasms; Lymphoma; Methyltransferases; Mice; Nitrogen Mustard Compounds; O(6)-Methylguanine-DNA Methyltransferase; Phenotype; Temozolomide | 1987 |
[CYVADIC therapy of T cell lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; T-Lymphocytes; Vincristine | 1986 |
Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Cell Line; Complement System Proteins; Cross Reactions; Cytotoxicity Tests, Immunologic; Dacarbazine; Leukemia L1210; Lymphoma; Male; Mice; Mice, Inbred BALB C | 1985 |